DE60206762D1 - Hexahydroazepino[4,5-g]indole und -indoline als 5-ht-rezeptor-liganden - Google Patents

Hexahydroazepino[4,5-g]indole und -indoline als 5-ht-rezeptor-liganden

Info

Publication number
DE60206762D1
DE60206762D1 DE60206762T DE60206762T DE60206762D1 DE 60206762 D1 DE60206762 D1 DE 60206762D1 DE 60206762 T DE60206762 T DE 60206762T DE 60206762 T DE60206762 T DE 60206762T DE 60206762 D1 DE60206762 D1 DE 60206762D1
Authority
DE
Germany
Prior art keywords
sup
hexahydroazepino
indolines
indole
receptor ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60206762T
Other languages
English (en)
Other versions
DE60206762T2 (de
Inventor
Jian-Min Fu
Kay Morris
Glenn Romero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co LLC filed Critical Pharmacia and Upjohn Co LLC
Application granted granted Critical
Publication of DE60206762D1 publication Critical patent/DE60206762D1/de
Publication of DE60206762T2 publication Critical patent/DE60206762T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60206762T 2001-07-13 2002-07-10 Hexahydroazepino(4,5-g)indole und -indoline als 5-ht rezeptor-liganden Expired - Fee Related DE60206762T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30530501P 2001-07-13 2001-07-13
US305305P 2001-07-13
PCT/US2002/019804 WO2003006466A1 (en) 2001-07-13 2002-07-10 Hexahydroazepino (4, 5-g) indoles and indolines as 5-ht receptor ligands

Publications (2)

Publication Number Publication Date
DE60206762D1 true DE60206762D1 (de) 2006-03-02
DE60206762T2 DE60206762T2 (de) 2006-07-13

Family

ID=23180257

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60206762T Expired - Fee Related DE60206762T2 (de) 2001-07-13 2002-07-10 Hexahydroazepino(4,5-g)indole und -indoline als 5-ht rezeptor-liganden

Country Status (11)

Country Link
US (1) US7022694B2 (de)
EP (1) EP1406902B1 (de)
JP (1) JP2005522408A (de)
AT (1) ATE307133T1 (de)
BR (1) BR0211140A (de)
CA (1) CA2452610A1 (de)
DE (1) DE60206762T2 (de)
DK (1) DK1406902T3 (de)
ES (1) ES2250667T3 (de)
MX (1) MXPA04000358A (de)
WO (1) WO2003006466A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006500376A (ja) * 2002-08-20 2006-01-05 イーライ・リリー・アンド・カンパニー ヒスタミンｈ３受容体アンタゴニストとしての置換アゼピン、製造および治療上の使用
US7211574B2 (en) 2002-08-29 2007-05-01 Schering Corporation Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders
PL1720836T3 (pl) 2004-02-25 2014-09-30 Lilly Co Eli 6-podstawione 2,3,4,5-tetrahydro-1h-benzo [d]azepiny jako agoniści receptora 5-ht2c
EP2248524A3 (de) 2004-08-25 2011-03-09 Takeda Pharmaceutical Company Limited Mittel zur prävention/behandlung von stressbedingter harninkontinenz und vorsorgeuntersuchungsverfahren dafür
JP5249031B2 (ja) 2005-09-01 2013-07-31 イーライ リリー アンド カンパニー ５−ＨＴ２Ｃ受容体アゴニストとしての６−Ｎ結合型へテロ環置換された２，３，４，５−テトラヒドロ−１Ｈ−ベンゾ［ｄ］アゼピン
US8420631B2 (en) 2005-09-01 2013-04-16 Eli Lilly And Company 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
SI1924561T1 (sl) 2005-09-01 2013-02-28 Eli Lilly And Company 6-arilalkilamino-2,3,4,5-tetrahidro-1h-benzo(d)azepini kot agonisti 5-ht2c receptorja
WO2007028082A1 (en) 2005-09-01 2007-03-08 Eli Lilly And Company 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
EP2742936A1 (de) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Kondensierte heterocyclische Verbindung und ihre Verwendung
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
EP2510949A4 (de) 2009-12-11 2013-11-13 Astellas Pharma Inc Therapeutikum für fibromyalgie
WO2015171514A1 (en) 2014-05-05 2015-11-12 Zhengbing Cao Antimicrobial surface coatings
EP3733204A4 (de) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited Therapeutikum für belastungsinkontinenz und stuhlinkontinenz
EP3753924A1 (de) * 2019-06-18 2020-12-23 AnaMar AB Neue tricyclische 5-ht2-antagonisten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK26793D0 (da) 1993-03-10 1993-03-10 Novo Nordisk As Benzofuranyl- eller dihydrobenzofuranyl-substituerede tricycliske benzazepiner, der anvendelse og fremstilling
JP3164371B2 (ja) 1994-09-14 2001-05-08 ノイロサーチ アクティーゼルスカブ インドール−２，３−ジオン−３−オキシム誘導体、その製造および使用
UA54403C2 (uk) 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
WO1998040385A1 (en) 1997-03-07 1998-09-17 Novo Nordisk A/S 4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
NZ507259A (en) 1998-03-31 2003-07-25 Neurosearch As Indole-2,3-dione-3-oxime derivatives for therapeutic use
GB9918965D0 (en) * 1999-08-11 1999-10-13 Cerebrus Ltd Chemical compounds xxi

Also Published As

Publication number Publication date
US20030060458A1 (en) 2003-03-27
MXPA04000358A (es) 2004-05-04
DE60206762T2 (de) 2006-07-13
WO2003006466A1 (en) 2003-01-23
ATE307133T1 (de) 2005-11-15
CA2452610A1 (en) 2003-01-23
JP2005522408A (ja) 2005-07-28
EP1406902A1 (de) 2004-04-14
BR0211140A (pt) 2005-10-25
ES2250667T3 (es) 2006-04-16
US7022694B2 (en) 2006-04-04
DK1406902T3 (da) 2006-01-30
EP1406902B1 (de) 2005-10-19

Similar Documents

Publication Publication Date Title
NO20023934D0 (no) Nye forbindelser
SE0300119D0 (sv) Novel compounds
NO20026064D0 (no) Nye forbindelser
SE0103836D0 (sv) Novel compounds
ATE316083T1 (de) Adamantanderivate
HK1070054A1 (en) Arylsulfonyl derivatives with5-ht6 receptor affinity
DE60305484D1 (de) Verbindungen und deren verwendung als 5-ht inhibitore
DE60206762D1 (de) Hexahydroazepino[4,5-g]indole und -indoline als 5-ht-rezeptor-liganden
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
IL174678A0 (en) Arylindenophyridines and arylindenophyrimidines and their use as adenosine a2a receptor antagonist
SG171471A1 (en) New benzimidazole derivatives
DE60208694D1 (de) Piperidinylmorpholinylderivate als modulatoren der aktivität des chemokinrezeptors
WO2003024976A3 (en) Tricyclic indole derivatives as 5-ht ligands
MXPA04000036A (es) Benzofuranos sustituidos con (hetero) arilo como ligandos 5-ht.
DE602006013828D1 (en) 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren
ATE274515T1 (de) Pyrazolopyridinderivate
WO2003045940A3 (en) Benzazepine derivatives and their use as 5-ht ligands
SE0202693D0 (sv) Compounds
WO2003076426A3 (en) Pyridinyloxy derivatives as 5-ht receptor ligands
ATE406363T1 (de) Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten
ATE373000T1 (de) Pyrazolopyridin-derivate als antiherpesmittel
MXPA04001201A (es) Derivados tetraciclicos de indol como ligandos del receptor de 5-ht.
GB0309440D0 (en) Quinolone derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee